Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 5, Number 1—February 1999

Perspective

The Economic Impact of Staphylococcus aureus Infection in New York City Hospitals

Robert J. Rubin, Catherine A. Harrington, Anna Poon, Kimberly Dietrich, Jeremy A. Greene, and Adil Moiduddin
Author affiliations: The Lewin Group, Fairfax, Virginia, USA

Main Article

Table 3

Incidence of Staphylococcus aureus infections from research or clinical panel

Type of infection Description S. aureus % Reference
Bacteremia Staphylococcal septicemia 50 30
Bacteremia 15 31,32
Infection and inflammatory reaction due to internal vascular device, implant, and graft 16 4
Endocarditis Acute and subacute bacterial endocarditis 30 Clinical panel
Infection and inflammatory reaction due to cardiac device, implant, and graft 14 33
Surgical site infection Disruption of operation wound and postoperative infection 20 4
Osteomyelitis Acute and chronic osteomyelitis 50 34,35
Septic arthritis Pyogenic arthritis 11 (age <5 yr) 33
33 (age 5-18 yr)
55 (age >18 yr)
Infection and inflammatory reaction due to internal joint prosthesis 25 33

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO